ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026

Clarifying the romosozumab "Super-Responder" phenotype: response to methodological concerns.

Alberto Ghielmetti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.